Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspectiveYang Yang, Qiu Li, Shuo Li et al.|Signal Transduction and Targeted Therapy|2022Cited by 257
Cost‐effectiveness analysis of cabozantinib as second‐line therapy in advanced hepatocellular carcinomaWei‐Ting Liao, Qiu Li|Liver International|2019Cited by 50
Glucose-6-phosphate dehydrogenase neutralizes stresses by supporting reductive glutamine metabolism and AMPK activationBenfu Zhong, Binghui Li, Dewei Jiang et al.|Signal Transduction and Targeted Therapy|2021Cited by 29